These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33761608)

  • 41. CRISPR/Cas9-mediated deletion of lncRNA Gm26878 in the distant Foxf1 enhancer region.
    Szafranski P; Karolak JA; Lanza D; Gajęcka M; Heaney J; Stankiewicz P
    Mamm Genome; 2017 Aug; 28(7-8):275-282. PubMed ID: 28405742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.
    Kun-Peng Z; Xiao-Long M; Chun-Lin Z
    Oncotarget; 2017 Sep; 8(42):71881-71893. PubMed ID: 29069754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targetable long non-coding RNAs in cancer treatments.
    Chen L; Dzakah EE; Shan G
    Cancer Lett; 2018 Apr; 418():119-124. PubMed ID: 29341880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LncRNAs in cancer: Regulatory and therapeutic implications.
    Nandwani A; Rathore S; Datta M
    Cancer Lett; 2021 Mar; 501():162-171. PubMed ID: 33359709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long Non-coding RNA FENDRR Acts as a miR-423-5p Sponge to Suppress the Treg-Mediated Immune Escape of Hepatocellular Carcinoma Cells.
    Yu Z; Zhao H; Feng X; Li H; Qiu C; Yi X; Tang H; Zhang J
    Mol Ther Nucleic Acids; 2019 Sep; 17():516-529. PubMed ID: 31351327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long noncoding RNAs: novel insights into gastric cancer.
    Fang XY; Pan HF; Leng RX; Ye DQ
    Cancer Lett; 2015 Jan; 356(2 Pt B):357-66. PubMed ID: 25444905
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein.
    Liu J; Du W
    Onco Targets Ther; 2019; 12():4287-4295. PubMed ID: 31213846
    [No Abstract]   [Full Text] [Related]  

  • 49. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers.
    Ma C; Shi X; Zhu Q; Li Q; Liu Y; Yao Y; Song Y
    Tumour Biol; 2016 Feb; 37(2):1437-44. PubMed ID: 26634743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long non-coding SNHG1 in cancer.
    Thin KZ; Tu JC; Raveendran S
    Clin Chim Acta; 2019 Jul; 494():38-47. PubMed ID: 30849309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNAs: An emerging powerhouse in the battle between life and death of tumor cells.
    Xiong XD; Ren X; Cai MY; Yang JW; Liu X; Yang JM
    Drug Resist Updat; 2016 May; 26():28-42. PubMed ID: 27180308
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long non-coding RNA FENDRR attenuates the stemness of non-small cell lung cancer cells via decreasing multidrug resistance gene 1 (MDR1) expression through competitively binding with RNA binding protein HuR.
    Gong F; Dong D; Zhang T; Xu W
    Eur J Pharmacol; 2019 Jun; 853():345-352. PubMed ID: 30981768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis and Therapy.
    Malissovas N; Ninou E; Michail A; Politis PK
    Curr Med Chem; 2019; 26(30):5649-5663. PubMed ID: 30182849
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNAs as novel biomarkers and therapeutic targets in head and neck cancers.
    Yang QQ; Deng YF
    Int J Clin Exp Pathol; 2014; 7(4):1286-92. PubMed ID: 24817925
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 May; 37(5):5657-61. PubMed ID: 26753962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ZEB1-AS1: A crucial cancer-related long non-coding RNA.
    Li J; Li Z; Leng K; Xu Y; Ji D; Huang L; Cui Y; Jiang X
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29226522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA SNHG15: A new budding star in human cancers.
    Shuai Y; Ma Z; Lu J; Feng J
    Cell Prolif; 2020 Jan; 53(1):e12716. PubMed ID: 31774607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA.
    Zhou H; Gao Z; Wan F
    Acta Biochim Biophys Sin (Shanghai); 2019 Feb; 51(2):123-130. PubMed ID: 30590378
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long non-coding RNAs in Oral squamous cell carcinoma: biologic function, mechanisms and clinical implications.
    Zhang L; Meng X; Zhu XW; Yang DC; Chen R; Jiang Y; Xu T
    Mol Cancer; 2019 May; 18(1):102. PubMed ID: 31133028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.